{"name":"Cugene Inc.","slug":"cugene-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQYXlpWWtJNGNLZHJEeWRMRnR6R0E2SVY5eElibzV2ZDlyaGZ0cDNLd3Z4V2hIVWpoZlA1LUw5SEd6SHRHbWNva1VQcUExU1FQN1lWV3pBN2M4aUktay16cGpCc2pPc2xsOWlwUzBvMXFGbmduaG5OdE1mZEM5aEdlN3BsNU1LNER4eWtScEpHb1hKUllUWm1OSndEM3MySmF6d3VPY0Q5ZVFjclBWUG5TMGNpODhhYWdiUlFQbV94T0g1T3RyZ2FnOWlhS0Z1c0xpNnExUGJBMTJfSGNGR01paGlveU5mazNqMV9JM1FIX1FlSzUwSjJ4VEtBWjVtWTVfTmpteW9n?oc=5","date":"2024-11-19","type":"regulatory","source":"PR Newswire","summary":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsight - PR Newswire","headline":"Systemic Lupus Erythematosus Clinical Trial Pipeline Gains Momentum as 120+ Key Companies at the Forefront | DelveInsigh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxONGl0M2pkNFg2SFZMdEFnS0Y1LVRkY3AtNXBpYUtLWkR6WXNOWUl3MlpEeHBZOV9jcUlnWVRscVpDWkJ0OHAxRlFYNGxiRU5mWGNaTS1GWEZJUjJoMG9ZQjlyUVBBYW10WUgzRUJ4eWtVcjk0ZHJzNnlqRGU0VVhzci1sQ0ZYRE16Qjk3N3dCZ1prWVNtUE5XYWROMTBieUxYR3JxUkk1Tlg4N3kzX2Z4LTY5RkhDZUpHX09TTmsyTGlqN0lQN0Iwck1pMXRXS2ctSkJDRE11VExQWm1zcjVTZXlEano4VEpHd1FCRTlrSG5Wbjd1Sk9Ma2k1dGtXQ3kwM1ktejBuc0hOaU5tX2l3TG9ydFhfYXQ4NnN1WGtocGlvcEp6bWZpOEJCc3FfTTVyY3c?oc=5","date":"2024-10-28","type":"trial","source":"PR Newswire","summary":"Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Treg Cell-based Therapies Clinical Trial Pipeline Appears Robust With 51+ Key Pharma Companies Actively Working in the T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE5XVFAxWnQ2ZlJZRk50eXNxVFktX25NNzFkLTJzSTY0Y1FNTlNld2dSSk5feDNwQTMtWmI1UWl2WnRzWjJ3MmM5OWVDbFpfb0MzV2VJTWdCamxkeHNOdFlDNTBB?oc=5","date":"2022-10-11","type":"pipeline","source":"PharmaLive","summary":"AbbVie 2022: Still immune - PharmaLive","headline":"AbbVie 2022: Still immune","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOb2djX3MxMDJwS3AtdGR1dTJONFY4YTBvX2pMOF9MZlNWUTBPa1ZxZUZIYmM1TzVGV245U0pyZm1VSTNycFRTc1NzR0VWWkJBc1ljWW5CVlg2NHI3VU8tam0zdS1wVHI2UGxWU196a3laRG1jVjNoSnRRdWVKTzd4V0s3X1FqYVhpbml5ekJB?oc=5","date":"2022-05-17","type":"deal","source":"pharmaphorum","summary":"AbbVie and Cugene partner to tackle autoimmune diseases - pharmaphorum","headline":"AbbVie and Cugene partner to tackle autoimmune diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPWlRnM2VUTm04V3ZfaFBEQ0J6Q3BoenZzWmx2MFd2ZFJ5bGxPLTZVQklMSFhoVEVIWEdYUkZHdS1VWV9YdW53WVl6OWVuYnBxR3MtcHNVeWRPVVZfY3RaYnRxU2tGUzl1WXkyRkF1Tlk4ckZCem5rWGJsbXhtMFc5cUx4cEhlTHJjZjc3aFpLUmpMOXlsRXF6djFPZndiWUJwVHhSc21xQWRHOXBWcGhvX3IxazNRcGxJ?oc=5","date":"2022-05-16","type":"pipeline","source":"Fierce Biotech","summary":"AbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up life post-Humira - Fierce Biotech","headline":"AbbVie coughs up nearly $50M for Cugene's autoimmune med in a bid to shore up life post-Humira","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}